Moutan Cortex Radicis inhibits inflammatory changes of gene expression in lipopolysaccharide-stimulated gingival fibroblasts

Journal of Natural Medicines

Volumn 67, Issue 3, 2013, Pages 576-589

  Yun, Cheol Sang ^a   Choi, Yeong Gon ^a   Jeong, Mi Young ^a   Lee, Je Hyun ^b   Lim, Sabina ^a  

^a Kyung Hee University   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

Anti inflammation; Gene array; HPLC; Periodontal disease

Indexed keywords

LIPOPOLYSACCHARIDE; PAEONIA SUFFRUTICOSA EXTRACT; PAEONIFLORIN; PEONOL;

ANALYTICAL EQUIPMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; CELL STIMULATION; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME ANALYSIS; GINGIVA; GINGIVAL FIBROBLAST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MICROARRAY ANALYSIS; MOUTAN CORTEX RADICIS; NUCLEOTIDE SEQUENCE; PAEONIA SUFFRUTICOSA; PERIODONTAL DISEASE; PHYTOCHEMISTRY; PLANT ROOT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

ANTI-INFLAMMATORY AGENTS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GINGIVA; GINGIVITIS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAEONIA; PHYTOTHERAPY; PLANTS, MEDICINAL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84879229807     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-012-0714-3     Document Type: Article

References (57)

1. Sheehan MP, Atherton DJ (1994) One-year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 130:488-493
2. Lin HC, Ding HY, Wu YC (1998) Two novel compounds from Paeonia suffructicosa. J Nat Prod 61:343-346
3. Ding HY, Wu YC, Lin HC, Chan YY, Wu PL, Wu TS (1999) Glycosides from Paeonia suffruticosa. Chem Pharm Bull 47:652-655
4. Hsiang CY, Hsieh CL, Wu SL, Lai IL, Ho TY (2001) Inhibitory effect of anti-pyretic and anti-inflammatory herbs on herpes simplex virus replication. Am J Chin Med 29:459-467
5. Au TK, Lam TL, Ng TB, Fong WP, Wan DC (2001) A comparison of HIV-1 integrase inhibition by aqueous and methanol extracts of Chinese medicinal herbs. Life Sci 68:1687-1694
6. Oh GS, Pae HO, Choi BM, Jeong S, Oh H, OH CS, Rho YD, Kim DH, Shin MK, Chung HT (2003) Inhibitory effects of the root cortex of Paeonia suffruticosa on interleukin-8 and macrophage chemoattractant protein-1 secretions in U937 cells. J Ethnopharmacol 84:85-89
7. Rho S, Chung HS, Kang M, Lee E, Cho C, Kim H, Park S, Kim HY, Hong M, Shin M, Bae H (2005) Inhibition of production of reactive oxygen species and gene expression profile by treatment of ethanol extract of Moutan Cortex Radicis in oxidative stressed PC12 cells. Biol Pharm Bull 28:661-666
8. Hong MH, Kim JH, Na SH, Bae H, Shin YC, Kim SH, Ko SG (2010) Inhibitory effects of Paeonia suffruticosa on allergic reactions by inhibiting the NF-kappaB/I kappaB-alpha signaling pathway and phosphorylation of ERK in an animal model and human mast cells. Biosci Biotechnol Biochem 74:1152-1156
9. Haffajee AD, Socransky SS (1994) Microbial etiological agents of destructive periodontal diseases. Periodontol 5:78-111
10. Jenkinson HF, Dymock D (1999) The microbiology of periodontal disease. Dent Update 26:191-197
11. Page RC (1999) Milestones in periodontal research and the remaining critical issues. J Periodontal Res 34:331-339
12. Kinane DF, Lappin DF (2002) Immune processes in periodontal disease: a review. Ann Periodontol 7:62-71
13. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T (2009) Cytokines differentially regulate CXCL10 production by interferon-gamma-stimulated or tumor necrosis factor-alpha-stimulated human gingival fibroblasts. J Periodontal Res 44:225-231
14. Daghigh F, Borghaei RC, Thornton RD, Bee JH (2002) Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J Periodontol 37:392-400
15. Wang PL, Ohura K, Fujii T, Oido-Mori M, Kowashi Y, Kikuchi M, Suetsugu Y, Tanaka J (2003) DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissues. Biochem Biophys Res Commun 305:970-973
16. Takashiba S, Takigawa M, Takahashi K, Myokai F, Nishimura F, Chihara T, Kurihara H, Nomura Y, Murayama Y (1992) Interleukin-8 is a major neutrophil chemotactic factor derived from cultured human gingival fibroblasts stimulated with interleukin-1 beta or tumor necrosis factor alpha. Infect Immun 60:5253-5258
17. Sakuta T, Tokuda M, Tamura M, Jimi E, Ikebe T, Koba T, Nagaoka S, Takada H (1998) Dual regulatory effects of interferon-alpha, -beta, and -gamma on interleukin-8 gene expression by human gingival fibroblasts in culture upon stimulation with lipopolysaccharide from Prevotella intermedia, interleukin-1alpha, or tumor necrosis factor-alpha. J Dent Res 77:1597-1605
18. Shimabukuro Y, Murakami S, Okada H (1996) Antigen-presenting-cell function of interferon gamma-treated human gingival fibroblasts. J Periodontal Res 31:217-228
19. Okada H, Murakami S (1998) Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9:248-266
20. Offenbacher S (1996) Periodontal diseases: pathogenesis. Ann Periodontal 1:821-878
21. Lamont RJ, Jenkinson HF (1998) Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 62:1244-1263
22. Nygaard V, Hovig E (2009) Methods for quantitation of gene expression. Front Biosci 14:552-569
23. Ha KCh, Coulombe-Huntington J, Majewski J (2009) Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation. BMC Genomics 10:519
24. Jeong MY, Kim YH, Lee NK, Lee JY, Herr Y, Lee JH, Lim S (2008) Antimicrobial effect on the periodontal pathogens and anti-inflammatory effect of Eriobotryae Folium. J Korean Orient Med 29:182-192 (in Korean)
25. An JH, Lee SY, Jeon JY, Cho KG, Kim SU, Lee MA (2009) Identification of gliotropic factors that induce human stem cell migration to malignant tumor. J Proteome Res 8:2873-2881
26. Kim SH, Kim SA, Park MK, Kim SH, Park YD, Na HJ, Kim HM, Shin MK, Ahn KS (2004) Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-alpha. Int Immunopharmacol 4:279-287
27. Booth V, Keizer DW, Kamphuis MB, Clark-Lewis I, Sykes BD (2002) The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry 41:10418-10425
28. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182:155-162
29. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD (2002) IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168:3195-3204
30. Tensen CP, Flier J, Van Der Raaij-Helmer EM, Sampat-Sardjoepersad S, Van Der Schors RC, Leurs R, Scheper RJ, Boorsma DM, Willemze R (1999) Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 112:716-722
31. Rani MR, Foster GR, Leung S, Leaman D, Stark GR, Ransohoff RM (1996) Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem 271:22878-22884
32. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K (1998) Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187:2009-2021
33. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, Koch AE, Moser B, Mackay CR (1998) The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101:746-754
34. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS (2003) Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 38:210-217
35. Spandau U, Toksoy A, Goebeler M, Bröcker EB, Gillitzer R (1998) MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions. J Invest Dermatol 111:1003-1009
36. Boorsma DM, Flier J, Sampat S, Ottevanger C, de Haan P, Hooft L, Willemze R, Tensen CP, Stoof TJ (1998) Chemokine IP-10 expression in cultured human keratinocytes. Arch Dermatol Res 290:335-341
37. Villagomez MT, Bae SJ, Ogawa I, Takenaka M, Katayama I (2004) Tumour necrosis factor-alpha but not interferon-gamma is the main inducer of inducible protein-10 in skin fibroblasts from patients with atopic dermatitis. Br J Dermatol 150:910-916
38. Ohta K, Shigeishi H, Taki M, Nishi H, Higashikawa K, Takechi M, Kamata N (2008) Regulation of CXCL9/10/11 in oral keratinocytes and fibroblasts. J Dent Res 87:1160-1165
39. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762-774
40. Terness P, Bauer TM, Röse L, Dufter C, Watzlik A, Simon H, Opelz G (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196:447-457
41. Ghahary A, Li Y, Tredget EE, Kilani RT, Iwashina T, Karami A, Lin X (2004) Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor. J Invest Dermatol 122:953-964
42. Holmes EW (1998) Expression and regulation of interferon-γ-induced tryptophan catabolism in cultured skin fibroblasts. J Interferon Cytokine Res 18:509-520
43. Sarkhosh K, Tredget EE, Uludag H, Kilani RT, Karami A, Li Y, Iwashina T, Ghahary A (2004) Temperature-sensitive polymer-conjugated IFN-γ induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG). J Cell Physiol 201:146-154
44. Mahanonda R, Sa-Ard-Iam N, Montreekachon P, Pimkhaokham A, Yongvanichit K, Fukuda MM, Pichyangkul S (2007) IL-8 and IDO expression by human gingival fibroblasts via TLRs. J Immunol 178:1151-1157
45. Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, Young RA, Aldovini A (2003) HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat Med 9:191-197
46. Ahrens I, Domeij H, Eisenhardt SU, Topcic D, Albrecht M, Leitner E, Viitaniemi K, Jowett JB, Lappas M, Bode C, Haviv I, Peter K (2011) Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Basic Res Cardiol 106:879-895
47. Papenfuss K, Cordier SM, Walczak H (2008) Death receptors as targets for anti-cancer therapy. J Cell Mol Med 12:2566-2585
48. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
49. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM (1997) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818
50. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821
51. Roberts AI, Devadas S, Zhang X, Zhang L, Keegan A, Greeneltch K, Solomon J, Wei L, Das J, Sun E, Liu C, Yuan Z, Zhou JN, Shi Y (2003) The role of activation-induced cell death in the differentiation of T-helper-cell subsets. Immunol Res 28:285-293
52. Zauli G, Rimondi E, Nicolin V, Melloni E, Celeghini C, Secchiero P (2004) TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. Blood 104:2044-2050
53. Lucas H, Bartold PM, Dharmapatni AA, Holding CA, Haynes DR (2010) Inhibition of apoptosis in periodontitis. J Dent Res 89:29-33
54. Mantovani A, Bonecchi R, Locati M (2006) Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 6:907-918
55. Wang J, Ou ZL, Hou YF, Luo JM, Shen ZZ, Ding J, Shao ZM (2006) Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 25:7201-7211
56. Wu FY, Ou ZL, Feng LY, Luo JM, Wang LP, Shen ZZ, Shao ZM (2008) Chemokine decoy receptor d6 plays a negative role in human breast cancer. Mol Cancer Res 6:1276-1288
57. Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM (2009) Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res 15:2962-2970